SOPHETHERA Trademark

Trademark Overview

On Friday, June 21, 2024, a trademark application was filed for SOPHETHERA with the United States Patent and Trademark Office. The USPTO has given the SOPHETHERA trademark a serial number of 98612498. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, January 15, 2025. This trademark is owned by Shine Technologies, LLC. The SOPHETHERA trademark is filed in the Pharmaceutical Products category with the following description:

Active pharmaceutical ingredients, isotopes and radioisotopes for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely lutetium-177, for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely non-carrier added lutetium-177; active pharmaceutical ingredients, namely, a radioisotope for the diagnosis and treatment of oncological diseases and disorders; active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases; active pharmaceutical ingredients that include terbium-149, terbium-152, terbium-155, or terbium-161; active pharmaceutical ingredients that include actinium-225.
sophethera

General Information

Serial Number98612498
Word MarkSOPHETHERA
Filing DateFriday, June 21, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, January 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesActive pharmaceutical ingredients, isotopes and radioisotopes for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely lutetium-177, for medical, therapeutic and diagnostic use; active pharmaceutical ingredients, namely non-carrier added lutetium-177; active pharmaceutical ingredients, namely, a radioisotope for the diagnosis and treatment of oncological diseases and disorders; active pharmaceutical ingredients, namely, a radioisotope for the purpose of increasing the effectiveness of pharmaceutical preparations in the treatment of oncological diseases; active pharmaceutical ingredients that include terbium-149, terbium-152, terbium-155, or terbium-161; active pharmaceutical ingredients that include actinium-225.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 21, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameShine Technologies, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressJanesville, WI 53546

Trademark Events

Event DateEvent Description
Friday, June 21, 2024NEW APPLICATION ENTERED
Tuesday, January 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 15, 2025NON-FINAL ACTION WRITTEN
Wednesday, January 15, 2025ASSIGNED TO EXAMINER
Wednesday, January 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 15, 2025NON-FINAL ACTION E-MAILED

Related Keywords

sophethera pharmaceutical active ingredients terbium namely treatment include diseases oncological radioisotope